CLB — CORE LABORATORIES INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About CORE LABORATORIES INC (CLB)
CORE LABORATORIES INC (CLB) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $3M. All data sourced from SEC 13F filings.
Based on recent institutional activity in CLB
No recent activity recorded.
How many top investors track CLB
Only 2 tracked investors report this position.
CLB Ownership Composition
How CORE LABORATORIES INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting CLB
- Ken GriffinMar 31, 2026Citadel AdvisorsShares170.1KValue$2.9M% Portfolio0.00%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares23.8KValue$399.6K% Portfolio0.00%
Recent activity
- No recent activity.
Frequently asked questions
- How many institutional investors hold CLB?
- 2 tracked institutional investors disclosed a position in CLB (CORE LABORATORIES INC) in their most recent 13F filing.
- Who is the largest institutional holder of CLB?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in CLB, valued at $3M.
- Did institutional ownership of CLB increase or decrease?
- Across recent 13F filings, tracked investors recorded 0 new positions, 0 increased, 0 reduced, and 0 fully exited CLB.
- Where does this CLB ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.